Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03031158 · ClinicalTrials.gov registry record · NA

Hip-spine Intervention for Older Adults With Chronic Low Back Pain

A NA study of Low Back Pain, sponsored by University of Delaware.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT03031158 is a NA study of Low Back Pain that has completed, run by University of Delaware. The registered enrollment target is 24 participants, below the 504-participant average among 122 other Low Back Pain trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03031158, a NA study of Low Back Pain, has completed, sponsored by University of Delaware.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

Low back pain (LBP) is extremely common in older adults and is associated with a host of negative consequences, including decreased physical function and increased healthcare utilization. Among older adults with LBP, hip impairments indicative of hip joint disease are more prevalent and associated with greater disability than among older adults without LBP. This study will investigate a novel intervention designed to improve LBP-related disability by combining a typical spine-focused exercise program with a hip-focused intervention.

Conditions Studied

Interventions

  • BEHAVIORAL SFEX+H
  • BEHAVIORAL SFEX

Study Locations (1)

Delaware

  • University of Delaware - Newark

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2017-02-01
Est. Completion 2018-03-13
Phase NA

Sponsor

University of Delaware

106 total trials

What the Registry Record Tells You About NCT03031158

The ClinicalTrials.gov registry entry for NCT03031158 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 504-participant average among 122 other Low Back Pain trials with a reported enrollment target (95% lower). The listed sponsor is University of Delaware, which has 106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which SFEX+H is the first listed.

NCT03031158 reports 1 study location spanning 1 distinct geographic area - top geographies include Delaware.

Frequently Asked Questions

What is clinical trial NCT03031158 about?

NCT03031158 is a clinical study titled "Hip-spine Intervention for Older Adults With Chronic Low Back Pain". Low back pain (LBP) is extremely common in older adults and is associated with a host of negative consequences, including decreased physical function and increased healthcare utilization. Among older adults with LBP, hip impairments indicative of hip joint disease are more prevalent and associated w...

What is the current status of trial NCT03031158?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2017-02-01. Estimated completion is 2018-03-13.

What conditions does trial NCT03031158 study?

This clinical trial studies the following conditions: Low Back Pain.

What interventions are being tested in trial NCT03031158?

The interventions under investigation include: SFEX+H (BEHAVIORAL), SFEX (BEHAVIORAL).

Who is sponsoring clinical trial NCT03031158?

This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03031158 being conducted?

This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Low Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.